COVID-19 Impact on Global OTC Cough, Cold & Allergy Medicine Market Size, Status and Forecast 2020-2026
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by OTC Cough, Cold & Allergy Medicine Revenue
- 1.4 Covid-19 Implications on Market by Type
- 1.4.1 Global OTC Cough, Cold & Allergy Medicine Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Tablet
- 1.4.3 Solution
- 1.4.4 Drops
- 1.4.5 Capsule
- 1.4.6 Granules
- 1.4.7 Syrup
- 1.4.8 Pills
- 1.5 Market by Application
- 1.5.1 Global OTC Cough, Cold & Allergy Medicine Market Share by Application: 2020 VS 2026
- 1.5.2 Baby
- 1.5.3 Toddler
- 1.5.4 Preschool Children
- 1.5.5 School-age Children
- 1.5.6 Adult
- 1.6 Coronavirus Disease 2019 (Covid-19): OTC Cough, Cold & Allergy Medicine Industry Impact
- 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.6.2 Covid-19 Impact: Commodity Prices Indices
- 1.6.3 Covid-19 Impact: Global Major Government Policy
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends
- 2.1 Covid-19 Implications on Global OTC Cough, Cold & Allergy Medicine Market Perspective (2015-2026)
- 2.2 Covid-19 Implications on Global OTC Cough, Cold & Allergy Medicine Growth Trends by Regions
- 2.2.1 OTC Cough, Cold & Allergy Medicine Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 OTC Cough, Cold & Allergy Medicine Historic Market Share by Regions (2015-2020)
- 2.2.3 OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 OTC Cough, Cold & Allergy Medicine Market Growth Strategy
- 2.3.6 Primary Interviews with Key OTC Cough, Cold & Allergy Medicine Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
- 3.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Market Size
- 3.1.1 Global Top OTC Cough, Cold & Allergy Medicine Players by Revenue (2015-2020)
- 3.1.2 Global OTC Cough, Cold & Allergy Medicine Revenue Market Share by Players (2015-2020)
- 3.1.3 Global OTC Cough, Cold & Allergy Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio
- 3.2.1 Global OTC Cough, Cold & Allergy Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by OTC Cough, Cold & Allergy Medicine Revenue in 2019
- 3.3 OTC Cough, Cold & Allergy Medicine Key Players Head office and Area Served
- 3.4 Key Players OTC Cough, Cold & Allergy Medicine Product Solution and Service
- 3.5 Date of Enter into OTC Cough, Cold & Allergy Medicine Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
- 4.1 Global OTC Cough, Cold & Allergy Medicine Historic Market Size by Type (2015-2020)
- 4.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
- 5.1 Global OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
- 5.2 Global OTC Cough, Cold & Allergy Medicine Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
- 6.1 North America OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 6.2 OTC Cough, Cold & Allergy Medicine Key Players in North America (2019-2020)
- 6.3 North America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 6.4 North America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
- 7.1 Europe OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 7.2 OTC Cough, Cold & Allergy Medicine Key Players in Europe (2019-2020)
- 7.3 Europe OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 7.4 Europe OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
8 China Impact of COVID-19
- 8.1 China OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 8.2 OTC Cough, Cold & Allergy Medicine Key Players in China (2019-2020)
- 8.3 China OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 8.4 China OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
- 9.1 Japan OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 9.2 OTC Cough, Cold & Allergy Medicine Key Players in Japan (2019-2020)
- 9.3 Japan OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 9.4 Japan OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
- 10.1 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 10.2 OTC Cough, Cold & Allergy Medicine Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 10.4 Southeast Asia OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
11 India Impact of COVID-19
- 11.1 India OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 11.2 OTC Cough, Cold & Allergy Medicine Key Players in India (2019-2020)
- 11.3 India OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 11.4 India OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
- 12.1 Central & South America OTC Cough, Cold & Allergy Medicine Market Size (2015-2020)
- 12.2 OTC Cough, Cold & Allergy Medicine Key Players in Central & South America (2019-2020)
- 12.3 Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Type (2015-2020)
- 12.4 Central & South America OTC Cough, Cold & Allergy Medicine Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 Sanofi-Aventis
- 13.1.1 Sanofi-Aventis Company Details
- 13.1.2 Sanofi-Aventis Business Overview and Its Total Revenue
- 13.1.3 Sanofi-Aventis OTC Cough, Cold & Allergy Medicine Introduction
- 13.1.4 Sanofi-Aventis Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020))
- 13.1.5 Sanofi-Aventis Recent Development and Reaction to COVID-19
- 13.2 Johnson & Johnson Service
- 13.2.1 Johnson & Johnson Service Company Details
- 13.2.2 Johnson & Johnson Service Business Overview and Its Total Revenue
- 13.2.3 Johnson & Johnson Service OTC Cough, Cold & Allergy Medicine Introduction
- 13.2.4 Johnson & Johnson Service Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.2.5 Johnson & Johnson Service Recent Development and Reaction to COVID-19
- 13.3 Reckitt Benckiser Group
- 13.3.1 Reckitt Benckiser Group Company Details
- 13.3.2 Reckitt Benckiser Group Business Overview and Its Total Revenue
- 13.3.3 Reckitt Benckiser Group OTC Cough, Cold & Allergy Medicine Introduction
- 13.3.4 Reckitt Benckiser Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.3.5 Reckitt Benckiser Group Recent Development and Reaction to COVID-19
- 13.4 Novartis AG
- 13.4.1 Novartis AG Company Details
- 13.4.2 Novartis AG Business Overview and Its Total Revenue
- 13.4.3 Novartis AG OTC Cough, Cold & Allergy Medicine Introduction
- 13.4.4 Novartis AG Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.4.5 Novartis AG Recent Development and Reaction to COVID-19
- 13.5 GlaxoSmithKline
- 13.5.1 GlaxoSmithKline Company Details
- 13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
- 13.5.3 GlaxoSmithKline OTC Cough, Cold & Allergy Medicine Introduction
- 13.5.4 GlaxoSmithKline Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.5.5 GlaxoSmithKline Recent Development and Reaction to COVID-19
- 13.6 AstraZaneca
- 13.6.1 AstraZaneca Company Details
- 13.6.2 AstraZaneca Business Overview and Its Total Revenue
- 13.6.3 AstraZaneca OTC Cough, Cold & Allergy Medicine Introduction
- 13.6.4 AstraZaneca Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.6.5 AstraZaneca Recent Development and Reaction to COVID-19
- 13.7 Pfizer Inc.
- 13.7.1 Pfizer Inc. Company Details
- 13.7.2 Pfizer Inc. Business Overview and Its Total Revenue
- 13.7.3 Pfizer Inc. OTC Cough, Cold & Allergy Medicine Introduction
- 13.7.4 Pfizer Inc. Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.7.5 Pfizer Inc. Recent Development and Reaction to COVID-19
- 13.8 Sun Pharmaceutical Industries
- 13.8.1 Sun Pharmaceutical Industries Company Details
- 13.8.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
- 13.8.3 Sun Pharmaceutical Industries OTC Cough, Cold & Allergy Medicine Introduction
- 13.8.4 Sun Pharmaceutical Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.8.5 Sun Pharmaceutical Industries Recent Development and Reaction to COVID-19
- 13.9 Prestige Brands Holdings
- 13.9.1 Prestige Brands Holdings Company Details
- 13.9.2 Prestige Brands Holdings Business Overview and Its Total Revenue
- 13.9.3 Prestige Brands Holdings OTC Cough, Cold & Allergy Medicine Introduction
- 13.9.4 Prestige Brands Holdings Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.9.5 Prestige Brands Holdings Recent Development and Reaction to COVID-19
- 13.10 Procter & Gamble
- 13.10.1 Procter & Gamble Company Details
- 13.10.2 Procter & Gamble Business Overview and Its Total Revenue
- 13.10.3 Procter & Gamble OTC Cough, Cold & Allergy Medicine Introduction
- 13.10.4 Procter & Gamble Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 13.10.5 Procter & Gamble Recent Development and Reaction to COVID-19
- 13.11 Bristol-Myers Squib
- 10.11.1 Bristol-Myers Squib Company Details
- 10.11.2 Bristol-Myers Squib Business Overview and Its Total Revenue
- 10.11.3 Bristol-Myers Squib OTC Cough, Cold & Allergy Medicine Introduction
- 10.11.4 Bristol-Myers Squib Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.11.5 Bristol-Myers Squib Recent Development and Reaction to COVID-19
- 13.12 Merck
- 10.12.1 Merck Company Details
- 10.12.2 Merck Business Overview and Its Total Revenue
- 10.12.3 Merck OTC Cough, Cold & Allergy Medicine Introduction
- 10.12.4 Merck Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.12.5 Merck Recent Development and Reaction to COVID-19
- 13.13 Allergen
- 10.13.1 Allergen Company Details
- 10.13.2 Allergen Business Overview and Its Total Revenue
- 10.13.3 Allergen OTC Cough, Cold & Allergy Medicine Introduction
- 10.13.4 Allergen Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.13.5 Allergen Recent Development and Reaction to COVID-19
- 13.14 Toray Industries
- 10.14.1 Toray Industries Company Details
- 10.14.2 Toray Industries Business Overview and Its Total Revenue
- 10.14.3 Toray Industries OTC Cough, Cold & Allergy Medicine Introduction
- 10.14.4 Toray Industries Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.14.5 Toray Industries Recent Development and Reaction to COVID-19
- 13.15 Beijing Tongrentang
- 10.15.1 Beijing Tongrentang Company Details
- 10.15.2 Beijing Tongrentang Business Overview and Its Total Revenue
- 10.15.3 Beijing Tongrentang OTC Cough, Cold & Allergy Medicine Introduction
- 10.15.4 Beijing Tongrentang Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.15.5 Beijing Tongrentang Recent Development and Reaction to COVID-19
- 13.16 Essence Pharmaceutical Group
- 10.16.1 Essence Pharmaceutical Group Company Details
- 10.16.2 Essence Pharmaceutical Group Business Overview and Its Total Revenue
- 10.16.3 Essence Pharmaceutical Group OTC Cough, Cold & Allergy Medicine Introduction
- 10.16.4 Essence Pharmaceutical Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.16.5 Essence Pharmaceutical Group Recent Development and Reaction to COVID-19
- 13.17 Jiangxi Heying Pharmaceutical
- 10.17.1 Jiangxi Heying Pharmaceutical Company Details
- 10.17.2 Jiangxi Heying Pharmaceutical Business Overview and Its Total Revenue
- 10.17.3 Jiangxi Heying Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.17.4 Jiangxi Heying Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.17.5 Jiangxi Heying Pharmaceutical Recent Development and Reaction to COVID-19
- 13.18 Diao Group Chengdu Pharmaceutical
- 10.18.1 Diao Group Chengdu Pharmaceutical Company Details
- 10.18.2 Diao Group Chengdu Pharmaceutical Business Overview and Its Total Revenue
- 10.18.3 Diao Group Chengdu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.18.4 Diao Group Chengdu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.18.5 Diao Group Chengdu Pharmaceutical Recent Development and Reaction to COVID-19
- 13.19 Shanghai Pharmaceutical
- 10.19.1 Shanghai Pharmaceutical Company Details
- 10.19.2 Shanghai Pharmaceutical Business Overview and Its Total Revenue
- 10.19.3 Shanghai Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.19.4 Shanghai Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.19.5 Shanghai Pharmaceutical Recent Development and Reaction to COVID-19
- 13.20 Harbin Children's Pharmaceutical
- 10.20.1 Harbin Children's Pharmaceutical Company Details
- 10.20.2 Harbin Children's Pharmaceutical Business Overview and Its Total Revenue
- 10.20.3 Harbin Children's Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.20.4 Harbin Children's Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.20.5 Harbin Children's Pharmaceutical Recent Development and Reaction to COVID-19
- 13.21 China Resources Sanjiu Pharmaceutical
- 10.21.1 China Resources Sanjiu Pharmaceutical Company Details
- 10.21.2 China Resources Sanjiu Pharmaceutical Business Overview and Its Total Revenue
- 10.21.3 China Resources Sanjiu Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.21.4 China Resources Sanjiu Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.21.5 China Resources Sanjiu Pharmaceutical Recent Development and Reaction to COVID-19
- 13.22 Xinjiang Quanan Pharmaceutical
- 10.22.1 Xinjiang Quanan Pharmaceutical Company Details
- 10.22.2 Xinjiang Quanan Pharmaceutical Business Overview and Its Total Revenue
- 10.22.3 Xinjiang Quanan Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.22.4 Xinjiang Quanan Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.22.5 Xinjiang Quanan Pharmaceutical Recent Development and Reaction to COVID-19
- 13.23 Jiangsu Huayang Pharmaceutical
- 10.23.1 Jiangsu Huayang Pharmaceutical Company Details
- 10.23.2 Jiangsu Huayang Pharmaceutical Business Overview and Its Total Revenue
- 10.23.3 Jiangsu Huayang Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.23.4 Jiangsu Huayang Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.23.5 Jiangsu Huayang Pharmaceutical Recent Development and Reaction to COVID-19
- 13.24 Nanjing Chengong Pharmaceutical
- 10.24.1 Nanjing Chengong Pharmaceutical Company Details
- 10.24.2 Nanjing Chengong Pharmaceutical Business Overview and Its Total Revenue
- 10.24.3 Nanjing Chengong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.24.4 Nanjing Chengong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.24.5 Nanjing Chengong Pharmaceutical Recent Development and Reaction to COVID-19
- 13.25 Beijing Jiulong Pharmaceutical
- 10.25.1 Beijing Jiulong Pharmaceutical Company Details
- 10.25.2 Beijing Jiulong Pharmaceutical Business Overview and Its Total Revenue
- 10.25.3 Beijing Jiulong Pharmaceutical OTC Cough, Cold & Allergy Medicine Introduction
- 10.25.4 Beijing Jiulong Pharmaceutical Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.25.5 Beijing Jiulong Pharmaceutical Recent Development and Reaction to COVID-19
- 13.26 Livzon Group
- 10.26.1 Livzon Group Company Details
- 10.26.2 Livzon Group Business Overview and Its Total Revenue
- 10.26.3 Livzon Group OTC Cough, Cold & Allergy Medicine Introduction
- 10.26.4 Livzon Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.26.5 Livzon Group Recent Development and Reaction to COVID-19
- 13.27 Sinopharm Group
- 10.27.1 Sinopharm Group Company Details
- 10.27.2 Sinopharm Group Business Overview and Its Total Revenue
- 10.27.3 Sinopharm Group OTC Cough, Cold & Allergy Medicine Introduction
- 10.27.4 Sinopharm Group Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.27.5 Sinopharm Group Recent Development and Reaction to COVID-19
- 13.28 CSPC
- 10.28.1 CSPC Company Details
- 10.28.2 CSPC Business Overview and Its Total Revenue
- 10.28.3 CSPC OTC Cough, Cold & Allergy Medicine Introduction
- 10.28.4 CSPC Revenue in OTC Cough, Cold & Allergy Medicine Business (2015-2020)
- 10.28.5 CSPC Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
OTC Cough, Cold & Allergy Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OTC Cough, Cold & Allergy Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Cough, Cold & Allergy Medicine market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the OTC Cough, Cold & Allergy Medicine industry.
The key players covered in this study
Sanofi-Aventis
Johnson & Johnson Service
Reckitt Benckiser Group
Novartis AG
GlaxoSmithKline
AstraZaneca
Pfizer Inc.
Sun Pharmaceutical Industries
Prestige Brands Holdings
Procter & Gamble
Bristol-Myers Squib
Merck
Allergen
Toray Industries
Beijing Tongrentang
Essence Pharmaceutical Group
Jiangxi Heying Pharmaceutical
Diao Group Chengdu Pharmaceutical
Shanghai Pharmaceutical
Harbin Children's Pharmaceutical
China Resources Sanjiu Pharmaceutical
Xinjiang Quanan Pharmaceutical
Jiangsu Huayang Pharmaceutical
Nanjing Chengong Pharmaceutical
Beijing Jiulong Pharmaceutical
Livzon Group
Sinopharm Group
CSPC
Market segment by Type, the product can be split into
Tablet
Solution
Drops
Capsule
Granules
Syrup
Pills
Market segment by Application, split into
Baby
Toddler
Preschool Children
School-age Children
Adult
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global OTC Cough, Cold & Allergy Medicine status, future forecast, growth opportunity, key market and key players.
To present the OTC Cough, Cold & Allergy Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of OTC Cough, Cold & Allergy Medicine are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.